Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 49823
Corporate User License Price USD 2,250
Corporate User License Price INR 133
Site License Price USD 1,500
Site License Price INR 66
Request a Quote

Report Title

IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1,500
Enterprise Wide License USD 2,250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update



Executive Summary

IntegraGen SA (IntegraGen) is a biotechnology company that offers clinical genomic services to academic researchers and life sciences companies. The company provides advanced bioinformatics and biostatistical analytical tools and services. Its genomic services include clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics and microbial genomics. IntegraGen also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data services. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves patients, clinicians and researchers. The company has its presence in France and the US. IntegraGen is headquartered in Evry, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company IntegraGen SA

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

IntegraGen SA Company Snapshot 6

IntegraGen SA Company Overview 6

IntegraGen SA Pipeline Products and Clinical Trials Overview 6

IntegraGen SA-Pipeline Analysis Overview 8

Key Facts 8

IntegraGen SA-Major Products and Services 9

IntegraGen SA Pipeline Products by Development Stage 10

IntegraGen SA Pipeline Products Overview 12

ARISk Test-V2.2 12

ARISk Test-V2.2 Product Overview 12

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer 13

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer Product Overview 13

CLIA Test-Hepatocellular Carcinoma 14

CLIA Test-Hepatocellular Carcinoma Product Overview 14

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer 15

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer Product Overview 15

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer 16

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer Product Overview 16

IntegraGen SA-Key Competitors 17

IntegraGen SA-Key Employees 18

IntegraGen SA-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

IntegraGen SA, Recent Developments 20

Jul 07, 2016: IntegraGen reports strong revenue growth during first half of 2016 20

Jun 06, 2016: IntegraGen Presents Positive Data at 2016 ASCO Meeting on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer Enrolled in FIRE-3 Clinical Trial 20

Jan 14, 2016: IntegraGen Reports 2015 Revenues 21

Dec 02, 2015: IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker 21

Jun 01, 2015: IntegraGen Presents Results of Two Studies during 2015 ASCO Meeting with New Positive Data on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer 22

Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 23

Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 23

Dec 16, 2014: IntegraGen Collaborating with PICCOLO Study Investigators to Validate Hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker 24

May 19, 2014: IntegraGen Presents Data on New Version of the ARISk Test during the 13th Annual Meeting for Autism Research 24

May 15, 2014: IntegraGen Announces Publication of Study with Biomarker Associated with Survival in Metastatic Colorectal Cancer Patients Treated with Drug Therapy 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 27

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

IntegraGen SA Pipeline Products by Equipment Type 7

IntegraGen SA Pipeline Products by Development Stage 10

List of Tables

IntegraGen SA Pipeline Products and Clinical Trials Overview 6

IntegraGen SA Pipeline Products by Equipment Type 6

IntegraGen SA Pipeline Products by Indication 7

IntegraGen SA, Key Facts 8

IntegraGen SA, Major Products and Services 9

IntegraGen SA Number of Pipeline Products by Development Stage 10

IntegraGen SA Pipeline Products Summary by Development Stage 11

ARISk Test-V2.2-Product Status 12

ARISk Test-V2.2-Product Description 12

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer-Product Status 13

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer-Product Description 13

CLIA Test-Hepatocellular Carcinoma-Product Status 14

CLIA Test-Hepatocellular Carcinoma-Product Description 14

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer-Product Status 15

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer-Product Description 15

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer-Product Status 16

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer-Product Description 16

IntegraGen SA, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

IntegraGen SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand